Author: Dr. Neil Abbot, MERGE Purpose: This document explores the neurological aspects of Myalgic Encephalomyelitis (ME), focusing on recent findings of reduced brain gray matter volume in ME patients. It highlights the implications of these findings for understanding the disease’s pathophysiology and its impact on patients. Key Points: Neurological Symptoms in ME Central nervous system…
Purpose: This document, summarized by Dr. Neil Abbot from Dr. J. Gordon Parish’s detailed review, explores the clinical and historical understanding of Myalgic Encephalomyelitis (ME). It examines the disease’s origins, notable outbreaks, and its impact on muscles and the brain. Key Points: Historical Outbreaks of ME From 1934 to 1959, at least 23 documented epidemics…
Purpose: Prepared by ME Research Group for Education and Support (MERGE) in April 2002, this document evaluates the January 2002 report produced by the Chief Medical Officer’s (CMO) Working Group on Chronic Fatigue Syndrome (CFS)/Myalgic Encephalomyelitis (ME). MERGE highlights both the report’s positive strides and its shortcomings in addressing ME/CFS’s complex challenges, aiming to advocate…
Purpose: ME Research UK (formerly MERGE) announces funding for a longitudinal cohort study led by Dr. Julia Newton at the University of Newcastle. This study investigates autonomic dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and explores its implications for patient outcomes and mortality risk. Key Points: Research Objectives: The study aims to determine the prevalence…
Purpose: This article by Rowan Hooper, originally published in New Scientist on May 20, 2006, explores significant advancements in Chronic Fatigue Syndrome (CFS) research led by Dr. Jonathan Kerr. The focus is on uncovering genetic and physiological evidence of CFS, potentially leading to better diagnostics and treatments. Key Points: Gene Expression Studies Dr. Kerr’s team…
Author: Dr. Melvin Ramsay, Hon Consultant Physician, Royal Free Hospital Purpose: This document presents a clinical overview of Myalgic Encephalomyelitis (ME), its symptoms, potential causes, and the importance of early management. It argues for recognition of ME as an organic illness and highlights the profound physical debility and social misconceptions faced by patients. Key Points:…
Purpose: This document provides an overview of the challenges and achievements of the CFS Research Foundation, founded in 1993, in advancing research into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). It focuses on the foundation’s efforts to overcome historical misconceptions about the illness and its progress toward understanding the genetic basis of ME/CFS. Key Points: Challenges of…
Purpose: This review, authored by Professor Malcolm Hooper on June 24, 2018, critiques the BMJ Best Practice document on Chronic Fatigue Syndrome (CFS) authored by Professor James Baraniuk. It identifies significant issues related to the presentation, accuracy, and focus of the document, arguing that it misrepresents Myalgic Encephalomyelitis (ME) as a behavioral disorder rather than…
Purpose: This document is a joint submission from the 25% ME Group for the Severely Affected and Stonebird. It raises concerns about the inclusion of Myalgic Encephalomyelitis (ME) in the proposed categories of Complex Somatic Symptom Disorder (CSSD) and Simple Somatic Symptom Disorder (SSSD) in the DSM-V. The authors argue that these categorizations would misrepresent…
Purpose: This document, authored by Margaret Williams on December 27, 2011, critically evaluates Professor Simon Wessely’s article in The Journal of the Foundation for Science and Technology. It challenges Wessely’s assertions about Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), focusing on his claims regarding Graded Exercise Therapy (GET), the PACE trial, and the nature of ME/CFS. Key…